Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 12Tumor-Agnostic 6Breast 6Thoracic 2Other hematologic neoplasm 2Head & Neck 2Gastrointestinal 2Sarcoma 1Plasma cell 1Myeloid 1Gynecologic 1Genitourinary 1Endocrine 1Dermatologic 1Classical hematology 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Squamous Cell Carcinoma of Head and Neck 1Carcinoma, Hepatocellular 1

Interventions

pembrolizumab 158Carboplatin 147Cisplatin 130Pemetrexed 103Paclitaxel 89Nivolumab 71Radiotherapy 68Docetaxel 62Erlotinib Hydrochloride 58Gemcitabine 57Etoposide 44osimertinib 43Bevacizumab 43Cyclophosphamide 42durvalumab 41atezolizumab 35Cetuximab 33130-nm albumin-bound paclitaxel 26Radiosurgery 25fludarabine 23Ipilimumab 23Irinotecan 21Taxes 20Radiation 20Oxaliplatin 20Magnetic Resonance Spectroscopy 20Fluorouracil 20Gefitinib 19Everolimus 19Topotecan 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × copanlisib × Thoracic × Clear all
NCT04895579 2025-11-18

LCD

University of Kentucky

Phase 1 Completed
11 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03735628 2023-10-06

An Study to Evaluate the Safety and Efficacy of Copanlisib in Combination With Nivolumab in Patients With Advanced Solid Tumors

Bayer

Phase 1 Completed
16 enrolled
GastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡